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Abstract
Background
Decision aids can support informed choice in mammography screening, but for the German
mammography screening programme no systematically evaluated decision aid exists to
date. We developed a decision aid for women invited to this programme for the first time
based on the criteria of the International Patient Decision Aids Standards Collaboration.
Objective
To determine whether a decision aid increases informed choice about mammography
screening programme participation.
Methods
A representative sample of 7,400 women aged 50 was drawn from registration offices in
Westphalia-Lippe, Germany. Women were randomised to receive usual care (i.e., the stan-
dard information brochure sent with the programme’s invitation letter) or the decision aid.
Data were collected online at baseline, post-intervention, and 3 months follow-up. The pri-
mary outcome was informed choice. Secondary outcomes were the constituents of informed
choice (knowledge, attitude, intention/uptake), decisional conflict, decision regret, and deci-
sion stage. Outcomes were analysed using latent structural equation models and χ2-tests.
Results
1,206 women participated (response rate of 16.3%). The decision aid increased informed
choice. Women in the control group had lower odds to make an informed choice at post-
intervention (OR 0.26, 95% CI 0.18-0.37) and at follow-up (OR 0.66, 95% CI 0.46-0.94);
informed choices remained constant at 30%. This was also reflected in lower knowledge
and more decisional conflict. Post-intervention, the uptake intention was higher in the control
group, whereas the uptake rate at follow-up was similar. Women in the control group had a
more positive attitude at follow-up than women receiving the decision aid. Decision regret
and decision stage were not influenced by the intervention.
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Conclusion
This paper describes the first systematic evaluation of a newly developed decision aid for
the German mammography screening programme in a randomised controlled trial. Our
decision aid proved to be an effective tool to enhance the rate of informed choice and was
made accessible to the public.
Trial registration
German Clinical Trials Register DRKS00005176.
Introduction
Women aged 50 to 69 are invited to participate in the German mammography screening pro-
gramme (MSP). However, informed choice is only achieved in a small proportion of decisions
made about participation in the MSP [1]. This uninformed compliance [2] is a major public
health problem, mainly because it is unclear whether mammography screening is beneficial
[3]. Many women expect unrealistic benefits of this screening [4]. A decision is classified as
informed, if the decision maker has good knowledge about the options, her/his attitude is con-
gruent with the decision, and she/he then implements this decision [5]. To enable women
invited to the MSP to such an informed choice, they need to be informed about the existing
benefits and harms including their probability and to be supported in clarifying the meanings
of those benefits and harms for themselves [6]. Importantly, no correct course of action can be
determined [7]—only a personally preferred course of action.
Decision aids (DAs) are an effective way to support informed choices: they improve knowl-
edge about options, increase active engagement in decision making, lead to a higher propor-
tion of choices being in congruence with the decision maker‘s values, and lower decisional
conflict due to feeling uninformed or unclear about ones values [8]. A typical DA presents risk
information both numerically and graphically and includes a type of values clarification exer-
cise. The International Patient Decision Aid Standards Collaboration (IPDAS) [9] developed
very comprehensive and widely used standards for DAs. In the context of mammography
screening, DAs have the potential to increase the proportion of women making informed
choices [10].
Unfortunately, the magnitude of information materials for all kinds of health decisions is
contrasted by a paucity of high-quality decision aids [11]. Lenz et al., taking an inventory of
German language DAs, found 12 DAs that had been evaluated in a RCT [11] but none of these
was on mammography screening. Overall, two types of information materials on the MSP are
available: (1) materials published by the Kooperationsgemeinschaft Mammographie which
also offers the screening itself; and (2) materials published by health insurances. None of the
materials available for the German MSP at the time our study were sufficiently in line with
IPDAS criteria [9] or systematically evaluated in a RCT. We therefore developed an evidence-
based online interactive decision aid for the German MSP. Recently and after the end of our
data collection, a printed DA has been developed by the IQWiQ [12] but it has not been sys-
tematically evaluated in a RCT yet.
Internationally, DAs on mammography screening have been systematically evaluated. The
Cochrane Review [8] reports two DAs on mammography screening [10, 13] (see DAs 1 and 2
described below). Completively, the Inventory of Decision Aids of the Ottawa Hospital
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Research Institute [14] yields 5 DAs (other than our DA) on mammography screening: (1) a
DA for 40-year old women [13], (2) a DA for 70-year old women [10], (3) a DA for women
ages 40-49 for deciding screening start age and interval [15], (4) a DA for women with dense
breasts [16], and (5) a DA with the options of screening start at 40 or 50 [17]. None of these
DAs is targeted at an average risk population ages 50-69 and three did not present not having a
mammography as an option but instead compared different starting ages, screening intervals
or additional screening tests.
The DA for women aged 40 improved knowledge and increased the proportion of women
who had made a choice but did not affect the proportion of informed choices [13]. The DA for
women aged 70 increased knowledge and proportion of informed choices [10]. In a RCT com-
paring a DA for women aged 50 with information on overdetection to a DA without such
information [18], more women in the intervention group had adequate knowledge, fewer had
a positive attitude, and fewer intended to be screened. In a pre-post study with 75 women ages
40 to 49 [19], the DA reduced decisional conflict and had no effect on intention. Therefore, we
expect positive effects of our DA on informed choice, knowledge and decisional conflict.
Study objectives
The present study aimed to assess for the first time in Germany the effect of an interactive
online DA on informed choice in a RCT with 3 months follow-up. This RCT compared
women receiving a DA additional to usual care (i.e., the brochure of the MSP [20]) to women
only receiving usual care. The DA included both additional information (all cause mortality)
as well as a different presentation (crowd figure pictograms and values clarification exercise).
The primary objective was to assess whether the DA increases the proportion of women
making an informed choice. The secondary objectives were to evaluate whether the DA (1)
increases knowledge about the MSP, (2) changes attitudes on the MSP, (3) changes participa-
tion intentions, (4) reduces decisional conflict, and (5) reduces decision regret.
Methods
This study was conducted in Wesphalia-Lippe, Germany. In our non-blinded two-armed RCT
(German Clinical Trials Register DRKS00005176), the participating women were randomised
to receive either the DA (intervention group) or usual care (control group). The usual care
for women aged 50 in Germany involved, at the time of the study, an invitation to the MSP
accompanied by an information brochure (see [20]). This brochure contained written and
numerical information about the MSP. Both study groups received these standard materials;
the intervention group additionally received the DA. The online assessments were conducted
at baseline (T1), post-intervention (T2, two weeks after T1), and 3 months follow-up (T3).
The Ethics Commission of the Medical Association Westphalia-Lippe and the Medical Fac-
ulty of the University of Mu¨nster approved our study protocol. It was originally planned that
women would receive the baseline questionnaire and the DA as well as the post questionnaire
in one session. The baseline assessment was moved to two weeks before the intervention and
post questionnaire to keep the time needed to work through the DA and respond to the ques-
tionnaire to an acceptable level.
Our study invitation contained information about the content, purpose, and procedure of
the study including the information that our trial was conducted independent of the MSP.
Once written informed consent was obtained, the participating women were randomised to
the intervention or control group by the researchers through an allocation sequence generated
by a random number generator (Random.org). Women were only informed about their study
group at the second assessment, when they either received the DA or only the questionnaire.
Does a decision aid improve informed choice in mammography screening?
PLOS ONE | https://doi.org/10.1371/journal.pone.0189148 December 13, 2017 3 / 19
The invitation to the study was sent by post 3 weeks before the estimated arrival of the MSP
invitation (for more details, see the study protocol [6]). Three weeks after the postal invitation,
women consenting to study participation and providing their e-mail address received the link
to the baseline questionnaire (T1). Women were e-mailed the link to the second assessment
(T2) 2 weeks after the baseline assessment. At T2, women in the intervention group received a
link to the DA and the second assessment whereas women in the control group received a link
only to the second assessment. The link to the third assessment (T3) was e-mailed to the
women 3 months after T2. The screening appointment was assumed to have passed at this
time. A reminder was e-mailed 10 days after each survey. Participating women received all 3 e-
mails irrespective of their response to the previous questionnaire. Data were collected between
April and November 2014. All questionnaires were based on the questionnaire of the study
‘Informed Choice of German and Turkish Women for Participation in the MSP (InEMa)’
[21]. Modifications were made to make it suitable for evaluating an intervention and to be
used Online (for the original questionnaire see [1]). All assessments were linked to each other
through a self-generated code.
Participants and recruitment
The sample of 7,400 women was randomly drawn from registration offices in Westphalia-
Lippe, North Rhine-Westphalia, Germany. Women were eligible for the trial if they were aged
50 (birth months of March to May 1964). Women with a potential Turkish migration back-
ground (according to a name algorithm [22]) were assigned to the InEMa study and accord-
ingly, our sample comprised only women without Turkish migration background.
Decision aid
The intervention group received an online DA which was designed to comply with IPDAS cri-
teria (see the BARMER website where our DA (the DA is in German) was made available after
the end of our study (https://www.barmer.de/gesundheit/praevention/krebspraevention/
krebsfrueherkennung/mammographie-13876) and the Decision Aid Library Inventory where
it was registered (https://decisionaid.ohri.ca/AZsumm.php?ID=1673)).
Our Online DA consisted of a static information part and an interactive part (see study pro-
tocol for a more detailed description [6]). Mathieu et al.’s DA [13] provided the basis for devel-
oping the structure of our DA. To meet IPDAS criteria [23], our DA presented the decision
options of participation or non-participation in the MSP in their relevant context.
In the information part, the chance of each outcome was expressed as event rate per 200
women screened every 2 years for 20 years using absolute numbers accompanied by crowd fig-
ure pictograms (see additional file of the protocol [6]). The advantages and disadvantages of
the MSP and their probabilities were described. This was compared to the option of no screen-
ing. The information women receive with the brochure in the MSP invitation [20] was
included in the information part of our DA (see quantitative information in Table 1).
The interactive part of the DA summarised the main points of the information part and
encouraged engagement with the information. It consisted of three steps. (1) The women
assigned the information items to the categories ‘in favour of mammography screening’, ‘nei-
ther for nor against such screening’, or ‘against the screening’. (2) They rated the importance
of each information item for the decision. (3) They made a choice. At the end, the participants
received a tailored summary based on their responses.
The content, design, and layout of the DA was informed by qualitative interviews with
women and by consulting experts for women‘s health and prevention (see the study protocol
[6]). The findings of pre-testing the DA resulted in additionally including the likelihood of all
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cause mortality. Information on all cause mortality was not part of the brochure and the first
draft of our DA. Since both experts and women in the qualitative pre-test, thought information
on this desirable, we included this information in our DA. As a result, the information content
of the DA differed from that of the brochure.
Outcome measures
Primary outcome measure. According to the three-dimensional classification framework
of Marteau et al. [5], the following dimensions were assessed and the continuous scales were
then dichotomously coded: (1) knowledge about the screening, (2) attitude towards the screen-
ing, and (3) intention/uptake (depending on measurement point). A choice to take part in the
MSP was considered to be informed, if a woman had adequate knowledge, positive attitude
and positive intention/uptake [5]. A choice not to participate in the MSP was considered to be
informed, if a woman had adequate knowledge, negative attitude and no intention/uptake [5].
Therefore, a dichotomous primary outcome resulted (informed/uninformed). Informed
choice is thus dependent on both the dimensions used as well as the cut-points employed to
dichotomise the continuous dimensions knowledge and attitude.
Secondary outcome measures. We used a similar approach to assess knowledge as in a
previous study on screening decisions [1] using seven multiple choice items: (1) target group
of the MSP, (2) number of women receiving a positive result, (3) whether a positive screening
Table 1. Comparison between decision aid and information brochure.
Information brochure Decision aid
General description Paper based booklet / PDF, 12 pages Online decision aid, information part and interactive part with 3
steps (assigning the information items to categories, rating the
importance of each information item, making a choice)
Visual aspects Short texts, no graphics or pictures, use of arrows as bullet
points, questions as headings
Short texts, bullet points, questions as headings, coloured text
boxes, crowd figure pictograms, rating scales, graphical
summary of personal responses, downloadable personal PDF at
the end
Key factual content General information about the MSP, quality of the MSP, breast
cancer and its risk factors, screening procedure, interval
cancers and symptoms, follow-up diagnostics, advantages and
disadvantages of the MSP
Target group of the DA, breast cancer mortality, overall
mortality, true positives, false positives, interval cancers,
overdiagnoses, screening procedure, symptoms of breast
cancer
Quantitative
information
Number of:
• positive and negative screening results
• follow-up diagnostics and biopsies
• breast cancer diagnoses
• interval cancers
• breast cancer deaths with mammography screening
• additional deaths without mammography screening
• overdiagnoses
Number of:
• breast cancer deaths with and without mammography
screening
• all-cause deaths with and without mammography screening
• negative screening results
• positive screening results/ follow-up diagnostics
• breast cancer diagnoses
• interval cancers
• overdiagnoses
Presentation of
quantitative
information
Absolute numbers presented in text (200 women with biannual
mammography screening over 20 years)
Absolute numbers supported by 3 crowd figure pictograms
consisting of 200 female pictograms (200 women over 20
years): (1) breast cancer mortality with biannual mammography
screening, (2) breast cancer mortality without mammography
screening, (3) false positives, breast cancer diagnoses, and
interval cancers with biannual mammography screening
Values clarification
exercise
None Interactive personal work sheet, evaluating information as in
favour of or against mammography screening, evaluating
importance of information, making a decision about participation
in the MSP, input window for remaining questions, downloadable
PDF summarising information and personal responses
https://doi.org/10.1371/journal.pone.0189148.t001
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result equals a diagnosis, (4) existence of false negatives, (5) number of diagnoses in screened
vs unscreened populations, (6) number of breast cancer deaths in screened vs unscreened pop-
ulations, and (7) existence of overtreatment. Questions 1 and 3 to 7 assessed conceptual knowl-
edge. Only Question 2 assessed numerical knowledge with four value ranges as response
options. This numerical information was considered to be especially important as the number
of women receiving a positive mammography screening result (as opposed to a negative
screening result) is the most proximal screening outcome. Each correct answer was scored 1
point; items were then summed to calculate the knowledge index (range 0 to 7). To calculate
informed choice, the knowledge index was dichotomised. We used a marking scheme for the
knowledge index that is similar to previous research [10, 24] and decided a priori that a mark
of 50% or above (score> 3) would be considered as adequate knowledge (see study protocol
for a more detailed description of all outcome measures [6]).
Attitude was measured according to the reasoned action approach of Fishbein and Ajzen
[25]. The four items were adapted from Marteau et al. [5] for use with mammography screen-
ing and rated on a five-point scale. To calculate informed choice, the scale ranging from -8 to
+8 was dichotomised: a scale score of 0 represented a positive attitude.
Intention to participate in the MSP and self-reported uptake were each measured using one
item: intention to participate in the MSP in the next 3 months (yes/no/undecided) and uptake
of the MSP in the last 3 months (MSP/opportunistic screening/none). To calculate informed
choice, intention was dichotomised as ‘participation in the MSP in the next 3 months’ and ‘no
participation in the MSP in the next 3 months’ and undecided women were excluded. In addi-
tion, women who reported at T2 to want to participate in opportunistic screening were
excluded. Consequently, only those were categorised as women with a positive intention, who
intended to participate in the MSP in the next 3 months (this category did not include women
intending to participate in opportunistic screening or intending to participate in the MSP at
some time beyond the three months), and only those were categorised as women with a nega-
tive intention, who neither intended to participate in the MSP nor in opportunistic screening
in the next 3 months (this category also did not include undecided women). At T3, behaviour
was dichotomised as ‘participation in the MSP’ and ‘no participation in the MSP’. Women
who had taken part in opportunistic screening were excluded.
Decisional conflict was measured using the 4-item SURE (Sure of myself; Understand
information; Risk-benefit ratio; Encouragement) test [26]. To calculate the total score ‘uncer-
tainty’ all items were summed (score range 0 to 4) with a high value indicating high decisional
conflict. Decision regret was measured at T3 using the Decision Regret Scale [27]. Decision
stage was measured with one item with the response options ‘not thought about’, ‘contemplat-
ing it’, ‘close to deciding’, and ‘choice already made’ [28].
Statistical analysis
Data were analysed with SPSS version 23.0 (IBM, Corp., Armonk, NY) and MPlus version 7.0
(Muthen & Muthen, Los Angeles, CA). Possible baseline differences between trial arms were
statistically tested with an α of.15. The impact of the DA on the primary outcome informed
choice was analysed using cross-sectional χ2-tests for all measurement points according to the
classification model of Marteau et al. [5].
All secondary outcomes with several indicators (i.e., knowledge, attitude, decisional con-
flict, decision regret) were modelled as latent variables which allowed to account for measure-
ment error and to test measurement invariance. Since measurement invariance is necessary
to conduct and interpret analyses on longitudinal multigroup data [29], measurement invari-
ance levels were tested across time and group before analyses of intervention effects were
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performed. Partial invariance (i.e., invariance of the majority of indicators, with some parame-
ters being freely estimated) was tested if full measurement invariance was not tenable. Partial
measurement invariance is unproblematic when only few loadings or intercepts are variant
[29]. Additionally, modelling outcomes as latent variables allowed us to apply full information
maximum likelihood estimation enabling us to include individuals with missing values in the
analysis. To test the intervention effect, autoregressive latent models [29] were applied with
group (0 = control, 1 = DA) predicting T2 and T3 latent outcomes. A first order autoregressive
effect of T1 on T2 and a second order autoregressive effect of T1 on T3 were specified. The
autoregressive path between T2 and T3 was fixed to 0 to allow a comparison to the baseline
measurement. For scale setting, all models were calculated using the Fixed-Factor-Method
[29].
Two types of latent analyses were conducted: (1) Numeric secondary outcome items form-
ing a continuous latent factor (i.e., attitude and decision regret) were analysed using confirma-
tory factor analysis (CFA). For these models, model fit was evaluated using the following
goodness-of-fit indices: Comparative Fit Index (CFI), Tucker-Lewis Index (TLI) and Root
Mean Square Error of Approximation (RMSEA). A model with acceptable fit should yield a
CFI 0.90, TLI 0.90 and a RMSEA 0.08 [29]. For the CFA models, the assumption of the
respective invariance level held, if the CFI difference to the model of the previous invariance
level was .01 [30]. For our analyses, data had to be strong-factorially invariant (loadings and
intercepts of the indicators equal over time and group) [29].
(2) Categorical secondary outcomes forming a continuous latent factor (i.e., decisional con-
flict and knowledge) were analysed using 2-parameter-logistic item factor analysis (IFA). For
these models, the assumption of invariance held, if the loglikelihood test was not significant
[31].
Single-indictor secondary outcomes were analysed with χ2-tests (intention and uptake) or a
Mann-Whitney-U-test (decision stage) according to their level of measurement.
Results
7,400 women were invited to take part in this study (see Fig 1). 1,206 women consented to take
part in the study and provided their e-mail address, through which they were contacted at the
three assessments. In our sample size calculation, we had determined a sample of 740 women
[6]. Compared to our estimated response rate of 15%, the actual response rate was 16.3%. At
T3 41.4% of women randomised responded. After code matching the data of all measurement
points, 1,052 datasets resulted (this includes women responding at any one measurement
point). Women who ever had breast cancer (n = 29), and women, who did not respond to this
question (n = 26), were excluded from the analyses. Women, who self-reported at T2 that the
appointment proposed in the MSP invitation already had passed, were also excluded (n = 84)
because they either would already have attended the screening or decided to not attend it.
Accordingly, the data of 913 women were analysed.
Baseline characteristics
Background and outcome variables were similar between groups (Table 2). Most participating
women had received at least 10 years of school education. For almost all German was their
main language. More than 60% had had a mammogram in the past; of those, more than half
had been conducted for screening purposes. Just under 60% had received the invitation to the
MSP and the associated brochure. About 90% had a statutory health insurance covering the
MSP.
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Fig 1. Consort flow diagram.
https://doi.org/10.1371/journal.pone.0189148.g001
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Primary analysis
Most women made no informed choice irrespective of time or group (see Table 3). In the con-
trol group the proportion of uninformed choices was constant at about 70%. The proportion
Table 2. Baseline characteristics, n (%).
Control Decision aid
General
Education
9 years 43 (9.7) 50 (11.2)
10 years 189 (42.6) 194 (43.4)
11 years 74 (16.7) 57 (12.8)
12 years 133 (30.0) 141 (31.5)
Other 5 (1.1) 5 (1.1)
Main language
German* 444 (99.8) 466 (100.0)
Internet information search per week
<1h 73 (16.0) 83 (18.1)
1h to <2h 157 (34.5) 146 (31.9)
2h to <5h 150 (33.0) 139 (30.3)
5h to <10h 52 (11.4) 55 (12.0)
>10h 23 (5.1) 35 (7.6)
Internet importance
important 264 (58.3) 263 (57.8)
neither nor 123 (27.2) 110 (24.2)
unimportant 66 (14.6) 82 (18.0)
Self-rated health
very good 90 (20.5) 87 (19.7)
good 254 (57.7) 243 (55.0)
neither nor 82 (18.6) 98 (22.2)
bad/very bad 14 (3.2) 14 (3.2)
Mother or sister with breast cancer 70 (15.8) 63 (14.1)
Mammography
Ever mammogram 284 (63.7) 289 (64.2)
If yes, reason for last mammogram:
- screening 160 (56.7) 144 (50.2)
- diagnostic 116 (41.1) 140 (48.8)
- don’t know 6 (2.1) 3 (1.0)
Invitation to MSP received 214 (55.4) 166 (59.7)
Health insurance
Health insurance:
- Statutory health insurance** 340 (76.6) 319 (72.8)
- Statutory & complementary private health insurance 57 (12.8) 79 (18.0)
- Private health insurance*** 37 (8.3) 30 (6.8)
- Other 10 (2.3) 10 (2.3)
Note.
*Including women providing more than 1 main language.
**Covers the MSP.
***Coverage of the MSP depends on the insurance.
https://doi.org/10.1371/journal.pone.0189148.t002
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of informed choices at T1 was similar between the groups (χ2 = 0.43, df = 1, p = .542). At T2
(χ2 = 57.20, df = 1, p< .001) and T3 (χ2 = 5.24, df = 1, p = .024) the proportion of informed
choices in the DA group was significantly higher. Thus, women in the control group had at T2
(OR 0.26, 95% CI 0.18-0.37) and T3 (OR 0.66, 95% CI 0.46-0.94) lower odds, to make an
informed choice than women in the DA group.
Secondary analysis
Knowledge. The proportion of women with adequate knowledge was similar between the
groups at T1, and being less than one-third, this proportion must be seen as low (Table 4).
Table 5 shows the model fit indices of the measurement invariance models and of the predictor
model. Since item 6 (Who is more likely to die of breast Cancer? Women participating in
the MSP/ Women not participating in the MSP/ Both the same) showed negative loadings
(women with a higher level of knowledge were less likely to answer the item correctly), it was
excluded. Since we assume in knowledge items that a correct response correspond with a
higher knowledge level, negative loading or loadings close to zero are not adequate to differen-
tiate between knowledge levels.
Partially strong measurement invariance was accepted. The paths from group to the latent
factor knowledge T2 (γ = 0.151, p = .010) and to the latent factor knowledge T3 (γ = 0.103,
p = .034) were significant indicating that at T2 and T3, the DA group had a higher knowledge
level than the control compared to T1.
Attitude. Both groups had, at all measurement points, a very positive attitude towards
participation in the MSP. Strong measurement invariance was accepted (Table 6). The path
(see Fig 2) from group to the latent factor attitude T2 was not significant (γ = −0.083, p = .170).
At T2, the DA group and control group had a similar attitude compared to T1. The path from
group to the latent factor attitude T3 was significant (γ = −0.229, p = .004). At T3, the DA
group had a more negative attitude than the control compared to T1.
Intention and uptake. At T1 and T2, the majority of women responded that they would
participate in the MSP within the next 3 months (see Table 7). At T3, in both groups, the
majority had participated in the MSP (additionally, more than 5% had conducted an opportu-
nistic mammography). At T1, a quarter of women was undecided. For intention at T1
(χ2 = 0.01, df = 1, p = 1.000) and uptake at T3 (χ2 = 0.27, df = 1, p = .653), there were no signifi-
cant differences between the groups. At T2 (χ2 = 7.56, df = 1, p = .007), there was a significant
difference: The proportion of those, who did not want to participate in the screening, was
higher in the DA group (18.1%) than in the control group (10.0%). Women in the control
group had higher odds to have a positive intention (OR 2.00, 95% CI 1.21-3.29) than women
in the DA group.
Table 3. Informed choice and its three dimensions, n (%).
Percentage of. . . Group T1 T2 T3
adequate knowledge DA 129 (28.6) 189 (66.8) 141 (51.3)
control 133 (29.8) 122 (31.4) 131 (40.2)
positive attitude DA 407 (90.0) 235 (83.0) 229 (84.2)
control 399 (88.7) 342 (87.5) 275 (85.1)
positive intention/completed screening DA 295 (87.3) 190 (81.9) 168 (65.4)
control 194 (87.5) 280 (90.0) 203 (67.4)
informed choice DA 87 (26.0) 142 (61.5) 99 (39.8)
control 94 (28.3) 89 (28.9) 88 (30.3)
https://doi.org/10.1371/journal.pone.0189148.t003
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Table 4. Decisional conflict, decision regret, and decision stage, M (SD).
Outcome Group T1 T2 T3
Knowledge DA 2.73 (1.41) 3.96 (1.33) 3.57 (1.16)
Control 2.79 (1.34) 2.92 (1.40) 3.21 (1.28)
Attitude DA 3.39 (2.91) 2.96 (3.41) 2.84 (3.51)
Control 3.33 (2.88) 3.20 (2.94) 3.39 (3.48)
Decisional conflict DA 1.49 (1.62) 0.52 (0.86) 0.62 (1.09)
Control 1.55 (1.59) 0.99 (1.37) 0.86 (1.21)
n (%) of Yes-responses
Understand information DA 294 (65.9) 272 (97.8) 246 (88.8)
Control 284 (63.7) 308 (80.4) 275 (84.1)
Risk-benefit ratio DA 292 (65.3) 257 (92.1) 245 (88.8)
Control 287 (64.3) 295 (77.0) 264 (81.0)
Encouragement DA 260 (58.6) 233 (83.8) 218 (79.6)
Control 259 (58.5) 277 (73.1) 235 (71.9)
Sure of myself DA 264 (58.7) 207 (74.2) 222 (80.7)
Control 261 (58.3) 274 (70.8) 250 (77.2)
Decision regret DA - - 12.18 (15.31)
Control - - 12.69 (15.92)
Decision stage DA 3.33 (1.05) 3.67 (.71) -
Control 3.36 (1.019) 3.58 (.811) -
n (%) of categories
Not thought about it DA 39 (8.5) 3 (1.1) -
Control 37 (8.2) 9 (2.3) -
Thinking about both options DA 82 (17.9) 30 (10.7) -
Control 70 (15.6) 54 (13.8) -
Close to making a decision DA 25 (5.5) 23 (8.2) -
Control 35 (7.8) 29 (7.4) -
Made a decision DA 311 (68.1) 224 (80.0) -
Control 308 (68.4) 300 (76.5) -
https://doi.org/10.1371/journal.pone.0189148.t004
Table 5. Fit-information of 2-parameter-logistic item factor models.
Outcome Tested model Loglikelihood df AIC BIC ΔLoglikelihood Δdf p Pass?
Decisional conflict Configural invariant -4174.26 55 8458.53 8723.24 - - - -
Full invariant -4212.97 25 8475.94 8596.27 77.41 30 < .001 no
Partial invariant* -4193.85 27 8441.70 8571.66 39.17 28 .078 yes
DA as predictor -3611.88 18 7259.76 7346.40 - - - -
Knowledge Configural invariant** -6539.91 115 13309.83 13862.36 - - - -
Full invariant** -6630.46 65 13390.91 13703.21 181.09 50 < .001 no
Partial invariant** -6556.33 89 13290.66 13718.27 32.83 26 .167 yes
DA as predictor -6073.74 47 12241.48 12467.30 - - - -
Note. - Parameter not possible.
*In the DA group, the thresholds of 2 items at T2 were estimated freely.
** Convergence criterion .02.
https://doi.org/10.1371/journal.pone.0189148.t005
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Decisional conflict. Decisional conflict was similar in the DA and control groups at
T1 with average values around 1.5 on a scale of 0 to 4 (see Table 3). Partially strong measure-
ment invariance was accepted (Table 5). The paths from group to the latent factor decisional
conflict T2 (γ = 0.335, p< .001) and to the latent factor decisional conflict T3 were significant
(γ = 0.149, p = .042). At T2 and T3, the DA group had lower decisional conflict than the con-
trol compared to T1.
Decision regret. At T3, most women experienced no regret (control: 40.8%; DA: 42.9%).
Strong measurement invariance was accepted (Table 6). The path from group to T3 was not
significant (γ = −0.060, p = .498). At T3, the DA group had a similar level of decision regret as
the control group.
Decision stage. At T1 in both groups, 68% indicated they had already made a decision.
This percentage increased to 76.5% in the control at T2 and to 80.0% in the DA group. For
decision stage, there was neither a significant difference between groups at T1 (U = 101794.00,
z = −.32, p = .755) nor at T2 (U = 52676.00, z = −1.23, p = .220).
Table 6. Fit-information of confirmatory factor models.
Outcome Tested model χ2 df p RMSEA (90%CI) CFI ΔCFI TLI ΔTLI Pass?
Attitude Configural invariant 105.66 78 .020 .028 (.012-.041) .996 - .994 - yes
Weak invariant 118.62 93 .038 .025 (.006-.037) .996 .000 .995 + yes
Strong invariant 143.40 108 .013 .027 (.013-.038) .995 .001 .994 .001 yes
DA as predictor 176.31 62 < .001 .045 (.037-.053) .984 - .980 - -
Decision regret Configural invariant 65.47 10 < .001 .137 (.106-.169) .952 - .904 - yes
Weak invariant 74.27 14 < .001 .120 (.094-.148) .948 .004 .926 + yes
Strong invariant 80.03 18 < .001 .108 (.084-.132) .946 .002 .941 + yes
DA as predictor 61.795 9 < .001 .099 (.077-.124) .954 - .923 - -
Note. - Parameter not possible. + Improvement of parameter.
https://doi.org/10.1371/journal.pone.0189148.t006
Fig 2. Predictor model of attitude. Unstandardised parameters; a to d: constraints over time; intercepts constrained over time and not shown; residual
covariances estimated freely and not shown; A: important/unimportant, B: a good thing/a bad thing, C: pleasant/unpleasant, D: beneficial/harmful; group:
0 = control, 1 = DA.
https://doi.org/10.1371/journal.pone.0189148.g002
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Discussion
This was the first study that evaluated the impact of a newly developed online DA for the Ger-
man MSP in a randomised controlled trial. As hypothesised, the DA resulted in a greater pro-
portion of informed choices, a higher knowledge level, and less decisional conflict. Contrary to
our hypothesis, decision regret was not reduced by the DA. For attitude and intention/uptake,
we did not formulate specific hypotheses. Our results for these outcomes were mixed: depend-
ing on the measurement point, we either found a decrease or no effect of the DA on these
measures.
In the control group the proportion of uninformed choices was constant at about 70%. This
confirms the results of a previous German study, according to which very few decisions about
the MSP are made informed [1]. Our results at both post intervention and follow-up show that
our DA led to more informed decisions than the existing information materials, that were pro-
vided with the invitation, were able to achieve alone. Previous research on levels of informed
choice after exposure to a DA on mammography screening shows mixed results. Mathieu et al.
(2007) evaluating a DA for women aged 70 reported a greater proportion of women making
an informed choice [10] while Mathieu et al. (2010) in their cross-sectional study on women
aged 40 found no difference in the proportion of women making an informed choice [13].
Regarding our secondary outcomes, the DA showed different effects. The proportion of
adequate knowledge at baseline with less than one-third must be seen as low. Contrastingly,
Hersch et al. reported correct responses to knowledge items of over 70% at baseline in an Aus-
tralian study [18]. In a cross-sectional survey in the Netherlands, Agt et al. assessed only con-
ceptual knowledge and reported 95% of women to have sufficient knowledge [32]. These
differences may in part be explained by differences between mammography screening infor-
mation materials and programmes in the different countries. Another possible explanation is
that the different knowledge measures account for these wide discrepancies. Existing knowl-
edge measures differ in content, difficulty, number of items and response formats. Our DA
group had a higher knowledge level than the control group at post-intervention and follow-up.
This is in line with the Cochrane review according to which DAs in general lead to higher
knowledge than usual care [8]. Regarding a DA for mammography screening, Mathieu et al.
(2007) found a significant increase in knowledge [10]. Similarly, Mathieu et al. (2010) also
reported a significant effect of their DA on knowledge [13].
It remains unclear which component of our DA or which combination of components is
responsible for the knowledge increase. Crowd figures using circles or pictograms to indicate
the number of affected and unaffected people have been shown to increase accuracy of risk
perception [33, 34]. DAs always interact with other factors. Petrova et al. conducted an
Table 7. Intention and uptake for DA and control, n (%).
Group Intention T1 T2 Uptake T3
DA MSP 295 (65.3) 190 (68.3) MSP 168 (62.0)
no MSP* 43 (9.5) 44 (15.8) no screening 89 (32.8)
undecided 114 (25.2) 44 (15.8) opportunistic 14 (5.2)
Control MSP 294 (66.1) 280 (71.8) MSP 203 (61.9)
no MSP* 42 (9.4) 38 (9.7) no screening 98 (29.9)
undecided 109 (24.5) 72 (18.5) opportunistic 27 (8.2)
Note.
* Including women intending an opportunistic mammogram.
https://doi.org/10.1371/journal.pone.0189148.t007
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experiment on 3 presentation formats for statistical information about breast cancer (text, fact
box, visual aid) and found no main effect of information format on number of correct compre-
hension questions [35]. Presenting numerical information accompanied by a visual aid
improved knowledge compared to alternative formats only when perceived severity of the dis-
ease was not extremely high [35]. Previous beliefs about mammography screening as well as a
high level of fear of breast cancer interfere with comprehension of evidence based information
and thus hinder knowledge increase and informed choices [35].
Both groups had, at all measurement points, a very positive attitude towards participation in
the MSP. Hersch et al. and Agt et al. similarly reported that most women had a positive attitude
[18, 32]. Post-intervention, we found no differences between groups. In contrast, at follow-up,
the DA group had a more negative attitude than the control group. Our DA may have made the
women feel less positive about screening through increasing their knowledge about the low per-
sonal benefit of screening, but it remains questionable why this effect did not occur at post-
intervention. Similarly, Mathieu et al. reported no difference in attitude in their DA group [13].
At baseline and post-intervention, the majority of participating women responded that they
would participate in the MSP within the next 3 months. At T3, in both groups, the majority
had participated in the MSP. Intention to participate was lower in the DA group post-interven-
tion. The uptake rate was unaffected by our DA regardless of a lower post-intervention inten-
tion to participate. Regarding intention and uptake, the effect of DAs is not clear. One study
reported no effect on intention following a DA [36] whereas others did find a lower intention
following a DA [37] or in the DA group [13]. The situation is similar for uptake with research
showing no effect on uptake [10] as well as lower uptake in the DA group [24]. According to
the Cochrane review, DAs with an explicit values clarification exercise were more likely to lead
to a value congruent choice [8] but there is no clear effect on intention per se. Depending on
the type of screening or treatment offered, more information will have a positive, no, or a neg-
ative effect. This argument similarly applies to attitude.
The proportion of women at follow-up not having participated in the MSP was significantly
higher than the intention to not participate in the MSP at post-intervention. Apart from a true
change of mind, other explanations have to be taken into account. We assessed intention to
participate within the next 3 months. Accordingly, some women will have had the intention to
take part in the next three months but either received the invitation to the MSP so late that the
appointment at our third measurement point had not yet passed orsome barrier hindered an
intended attendanceand the appointment was postponed. Potentially, social desirability may
have been a factor influencing intention responses, since in a context where early detection is
seen as something good by society, an intention to not participate may be perceived as deviant
and thus not reported. Retrospective uptake responses may not be biased as strongly as screen-
ing attendance either has or has not occurred.
The DA group had lower decisional conflict than the control at both post-intervention and
follow-up. This is in congruence withthe Cochrane review reporting overall, a reduction in
decisional conflict following a DA [8]. Contrastingly, two randomised controlled studies on
mammography screening reported no effect of a DA on decisional conflict [10, 37] whereas
one study found lower decisional conflict [18]. However, this may be different for various sub-
groups of women resulting in opposing effects. Many women have decided before contact
with a DA [38]. This then may cause more decisional conflict if personal preference and scien-
tific evidence do not match; i.e., a DA can increase decisional conflict [38]. DAs are also seen
most positive by women who merely verify their previous decision with the DA [38]. At pres-
ent it is uncertain whether high decisional conflict is a good or a bad thing [24], since high
decisional conflict could be an indicator for an active deliberation process [39] as well as for
insufficient decision support.
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Most women experienced no decision regret and this was not affected by the DA. This is in
line with other research. According to the Cochrane review, only 7 studies assessed decision
regret and none reported statistically significant differences [8].
At baseline, the majority of women indicated they had already made a decision which is
similar to a RCT by Hersch et al. [18]. Our study groups were similar in decision stage at post-
intervention and follow-up. This may be explained by our DA only being relevant for women
who have not yet formed a decision. Thus, decision stage in our study would not have been
expected to alter since the majority had already made the decision leaving little room for deci-
sion process progression.
Strengths and limitations
Major strengths of this study were its design as a RCT and as one of the first the follow-up at 3
months. This allowed the evaluation of long-term effects of the DA (e.g., the persistence of
increased knowledge) and also of screening uptake. Importantly, another strength of this
research is that we developed and evaluated the DA in accordance with IPDAS criteria which
are designed to ensure a minimum level of quality for DAs. Our DA was systematically devel-
oped and evidence based. The brochure that was in use during our study and was thus the
usual care, had been in use since September 2010 and openly discussed benefits and harms of
the MSP [40]. Only some but not all statistics were presented in absolute numbers [41]. Gum-
mersbach and Abholz indicate that a graphical presentation of the numbers may have been
useful and that the probable lack of effect on overall mortality should be mentioned [41]. All 3
points were all fulfilled by our DA but not by the brochure.
Most respondents received the questionnaire at about the time of receipt of the official invi-
tation materials. This ensured a high relevance of the decision. Some women had not yet
received the invitation to the MSP and the associated brochure. Thus, the timing of the deci-
sion and the availability of usual care information materials was heterogeneous. Since the
information brochure is also available online, it remains speculative how whether the women
not yet having received their invitation had access to it.
To avoid the potential disruptive influence of previous screening experiences or habits,
only women aged 50 who are invited for the first time to the MSP were included in the study.
Our study achieved acceptable response and attrition rates but it has to be noted that women
participating in our study will likely have been different from those not participating: in partic-
ular, it can be assumed that they may have been more interested in mammography screening
as a topic and thus may probably have informed themselves about this topic more than the
general population.
Since the sample we drew from the population registries was representative except for
women with Turkish migration background, our results cannot be applied to this group. We
had almost no women in our sample whose main language did not include German. Women
whose mother tongue was not German may have been less likely to participate in our study.
In calculating informed choice, intention to participate in the MSP within the next three
months was used as one of 3 dimensions. Consequently, women whose appointment was at a
later date were classified as non-intenders and an artificial mismatch (or match) between atti-
tude and intention would be created due to the time frame of the intention question. This time
limitation may explain some of the inconsistencies between attitude and intention that have
been categorised as uninformed decision [1]. Nevertheless, a limitation of the period was
important for the validity of the question [25]. Assessed uptake at T3, since it was self-reported,
will have deviated to some degree from actual uptake.
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Using latent structural equation models for our analyses had several advantages. (1) We
could explicitly account for measurement error. (2) Testing measurement invariance across
time and groups enabled us to establish a crucial prerequisite for testing our intervention
effect. Measurement invariance entails that the same construct is measured regardless of time
or group. Thus, the item specific information is unaffected by these contextual factors [29]. (3)
In order to deal with missing values, we could apply full information maximum likelihood esti-
mation allowing us to include individuals with missing values in the analysis.
The knowledge index contained only some facts about the MSP. These have been carefully
selected, however, by no means cover the entire spectrum of possibly decision relevant facts.
Additionally, we had to exclude one item, which did not differentiate women with a high or
low knowledge level. It remains speculative, what caused this problem in this item.
Practice implications and future research
An important aspect for future research is the influence of affect on information processing,
especially since decisions about cancer screening involve counterintuitive evidence [35] like
overdiagnoses. When cancer is perceived as a severe condition, understanding of screening
statistics can be reduced [35]. Therefore, when the consequences of a decision are affect-rich
(e.g., when women experience fear of breast cancer) heuristic processes are engaged, which
neglect this probabilistic information [42]. Hence, for women in our study with strong previ-
ous beliefs, the effect of our DA may have been limited. Previous research showed that visual
aids have no benefits for women regarding breast cancer as highly severe condition [35]. These
women might have rather relied on established beliefs being less motivated to engage with the
visual aids than women experiencing less severe affect regarding breast cancer [35]. These
moderating and mediating factors will be interesting to assess in future research.
Since almost all trials on DAs fail to assess potential long-term effects on health or quality
of life [24]—and our study is no exception to this—it would be interesting not only to include
these measures but also to see how the different outcome groups of screening (false-positives,
negatives, true positives) affect these measures. We assessed screening outcomes, but in this
time span, to few events for any calculations occurred.
It can be hypothesised that the effect of the DA will be larger in women with higher health
literacy. It remains questionable in how far a one size fits all approach will ever be feasible for a
DA on the MSP. Not only should a DA be available in different languages and for different lev-
els of health literacy but also for women with differing existing knowledge levels and finally
with differing motivations to engage with this decision. A tailored approach therefore, may be
indicated in future DA developments. Alternatively, at least regarding health literacy levels, a
universal precautions approach may be beneficial although it may be difficult to keep the DA
to an acceptable length. A possibility may be to further develop the DA to include more
explanatory information sections that can be accessed if desired (e.g., as mouse hover boxes).
After the end of our study, the information brochure of the MSP has been updated [43]
and, additionally, was further developed into a DA and a concept for a future online version
[12]. The new materials have not yet been evaluated in an RCT and a comparison with our DA
would be interesting.
Conclusion
This is the first study to assess the impact of an online DA for the German MSP in a RCT. The
DA developed in this project is a valuable tool to support decision making and has been imple-
mented through making it publicly available on the website of the BARMER since December
2015. Since the DA has proven to be effective in supporting women to make an informed
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choice, the results are relevant to practice and the DA can be widely used to support women in
decision making. The DA also significantly increased women’s knowledge about the screening
and decreased decisional conflict.
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